Andres González-Guerra

Mr. Andres González-Guerra

European Molecular Biology Laboratory, Monterotondo, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cell
Verified
Journal Article
Closed access
JNJosé A. Nicolás-Ávila
José A. Nicolás-Ávila
ALAna V. Lechuga-Vieco
Ana V. Lechuga-Vieco
LELorena Esteban-Martínez
Lorena Esteban-Martínez
MSMaría Sánchez-Díaz
María Sánchez-Díaz
EGElena Díaz García
Elena Díaz García
AHAndrés Hidalgo
Andrés Hidalgo

6 July 2016 in Nature
Verified
Journal Article
Closed access
ALAna Latorre-Pellicer
Ana Latorre-Pellicer
RMRaquel Moreno-Loshuertos
Raquel Moreno-Loshuertos
ALAna Victoria Lechuga-Vieco
Ana Victoria Lechuga-Vieco
FSFatima Sanchez-Cabo
Fatima Sanchez-Cabo
CTCarlos Torroja
Carlos Torroja
JEJosé Antonio Enríquez
José Antonio Enríquez

28 March 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
RARebeca Acin-Perez
Rebeca Acin-Perez
ALAna Victoria Lechuga-Vieco
Ana Victoria Lechuga-Vieco
MMMaria del Mar Muñoz
Maria del Mar Muñoz
RNRocío Nieto-Arellano
Rocío Nieto-Arellano
CTCarlos Torroja
Carlos Torroja
JEJosé Antonio Enríquez
José Antonio Enríquez
Loss of OMA1 protects cardiomyocytes from death in three murine models of heart failure with diverse etiologies.

26 July 2021 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
MEMarc Emmenegger
Marc Emmenegger
ECElena De Cecco
Elena De Cecco
MHMarian Hruska‐Plochan
Marian Hruska‐Plochan
TETimo Eninger
Timo Eninger
MSMatthias M Schneider
Matthias M Schneider
AAAdriano Aguzzi
Adriano Aguzzi
While the initial pathology of Parkinson’s disease and other α‐synucleinopathies is often confined to circumscribed brain regions, it can spread and progressively affect adjacent and distant brain locales. This process may be controlled by cellular receptors of α‐synuclein fibrils, one of which was proposed to be the LAG3 immune checkpoint molecule. Here, we analysed the expression pattern of LAG3 in human and mouse brains. Using a variety of methods and model systems, we found no evidence for LAG3 expression by neurons. While we confirmed that LAG3 interacts with α‐synuclein fibrils, the specificity of this interaction appears limited. Moreover, overexpression of LAG3 in cultured human neural cells did not cause any worsening of α‐synuclein pathology ex vivo . The overall survival of A53T α‐synuclein transgenic mice was unaffected by LAG3 depletion, and the seeded induction of α‐synuclein lesions in hippocampal slice cultures was unaffected by LAG3 knockout. These data suggest that the proposed role of LAG3 in the spreading of α‐synucleinopathies is not universally valid.

17 January 2017 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
José Antonio CañasJosé Antonio Cañas
José Antonio Cañas
BSBeatriz Sastre
Beatriz Sastre
CMCarla Mazzeo
Carla Mazzeo
MFMar Fernández-Nieto
Mar Fernández-Nieto
JMJosé Manuel Rodrigo Muñoz
José Manuel Rodrigo Muñoz
Victoria Del PozoVictoria Del Pozo
Victoria Del Pozo
Eosinophils are able to secrete exosomes that have an undefined role in asthma pathogenesis. We hypothesized that exosomes released by eosinophils autoregulate and promote eosinophil function. Eosinophils of patients with asthma (n = 58) and healthy volunteers (n = 16) were purified from peripheral blood, and exosomes were isolated and quantified from eosinophils of the asthmatic and healthy populations. Apoptosis, adhesion, adhesion molecules expression, and migration assays were performed with eosinophils in the presence or absence of exosomes from healthy and asthmatic individuals. Reactive oxygen species (ROS) were evaluated by flow cytometry with an intracellular fluorescent probe and nitric oxide (NO) and a colorimetric kit. In addition, exosomal proteins were analyzed by mass spectrometry. Eosinophil-derived exosomes induced an increase in NO and ROS production on eosinophils. Moreover, exosomes could act as a chemotactic factor on eosinophils, and they produced an increase in cell adhesion, giving rise to a specific augmentation of adhesion molecules, such as ICAM-1 and integrin α2. Protein content between exosomes from healthy and asthmatic individuals seems to be similar in both groups. In conclusion, we found that exosomes from the eosinophils of patients with asthma could modify several specific eosinophil functions related to asthma pathogenesis and that they could contribute fundamentally to the development and maintenance of asthma.

2 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JTJosé Luis Torán
José Luis Torán
SASusana Aguilar
Susana Aguilar
JLJuan Antonio Lopez
Juan Antonio Lopez
CTCarlos Torroja
Carlos Torroja
JQJuan Antonio Quintana
Juan Antonio Quintana
Antonio BernadAntonio Bernad
Antonio Bernad
Studies in recent years have established that the principal effects in cardiac cell therapy are associated with paracrine/autocrine factors. We combined several complementary techniques to define human cardiac progenitor cell (CPC) secretome constituted by 914 proteins/genes; 51% of these are associated with the exosomal compartment. To define the set of proteins specifically or highly differentially secreted by CPC, we compared human mesenchymal stem cells and dermal fibroblasts; the study defined a group of growth factors, cytokines and chemokines expressed at high to medium levels by CPC. Among them, IL-1, GROa (CXCL1), CXCL6 (GCP2) and IL-8 are examples whose expression was confirmed by most techniques used. ELISA showed that CXCL6 is significantly overexpressed in CPC conditioned medium (CM) (18- to 26-fold) and western blot confirmed expression of its receptors CXCR1 and CXCR2. Addition of anti-CXCL6 completely abolished migration in CPC-CM compared with anti-CXCR2, which promoted partial inhibition, and anti-CXCR1, which was inefficient. Anti-CXCL6 also significantly inhibited CPC CM angiogenic activity. In vivo evaluation also supported a relevant role for angiogenesis. Altogether, these results suggest a notable angiogenic potential in CPC-CM and identify CXCL6 as an important paracrine factor for CPC that signals mainly through CXCR2.